FDA Grants Accelerated Approval for Alzheimer’s Drug | FDA
Description
The FDA approved a drug for the treatment of Alzheimer’s under the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides meaningful therapeutic advantage over existing treatments.